A case of hypereosinophilic syndrome presenting with chronic cough successfully treated with imatinib

Respirology

Volumn 14, Issue 2, 2009, Pages 302-304

  Kobayashi, Makoto ^a,b   Kubota, Tetsuya ^b   Uemura, Yoshiki ^b   Taguchi, Hirokuni ^b  

^a Hosogi Hospital   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

Airway inflammation; FIP1L1 PDGFRA fusion gene; Hypereosinophilic syndrome; Imatinib; Myeloproliferative variant

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; HYDROXYUREA; IMATINIB; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PREDNISOLONE;

ADULT; ANEMIA; ARTICLE; CASE REPORT; COUGHING; FUSION GENE; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIC SYNDROME; LABORATORY TEST; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; CHRONIC DISEASE; COUGH; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TREATMENT OUTCOME;

EID: 61349175834     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01467.x     Document Type: Article

References (12)

1. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975 54 : 1 27.
2. Brito-Babapulle F. The eosinophilias including the idiopathic hypereosinophilic syndrome. Br. J. Haematol. 2003 121 : 203 23.
3. Godlib J, Cools J, Malone JM, III., Schrier SL, Gilliland G et al. The FIP1L1-PDGFRa fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2004 103 : 2879 91.
4. Roche-Lestienne C, Lepers S, Soenen-Cornu V, Kahn J-E, Lai J-L et al. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia 2005 19 : 792 8.
5. Muller AMS, Martens UW, Hofmann SC, Bruckner-Tuderman L, Martelsmann R et al. Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature. Ann. Hematol. 2006 85 : 1 16.
6. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med. 2003 348 : 1201 14.
7. Simon HU, Plotz GS, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N. Engl. J. Med. 1999 341 : 1112 20.
8. Gleich JG, Leiferman KL. The hypereosinophilic syndromes: still more heterogeneity. Curr. Opin. Immunol. 2005 17 : 679 84.
9. Cools J. The hypereosinophilic syndrome: idiopathic or not, that is the question. Haematologica 2005 90 : 582 4.
10. Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br. J. Haematol. 2006 133 : 468 92.
11. Irwin RS, Madison JM. The diagnosis and treatment of cough. N. Engl. J. Med. 2000 343 : 1715 21.
12. Chung KF, Hew M, Score J, Jones AV, Reiter A et al. Cough and hypereosinophilia due to FIP1L1-PDGFRA fusion gene with tyrosine kinase activity. Eur. Respir. J. 2006 27 : 230 2.